Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Apr;40(4):359-70.
doi: 10.1007/s00249-011-0672-9. Epub 2011 Feb 3.

NMR and protein structure in drug design: application to cyclotides and conotoxins

Affiliations
Review

NMR and protein structure in drug design: application to cyclotides and conotoxins

Norelle L Daly et al. Eur Biophys J. 2011 Apr.

Abstract

Nuclear magnetic resonance spectroscopy (NMR) is a powerful technique for determining the structures, dynamics and interactions of molecules, and the derived information can be useful in drug design applications. This article gives a brief overview of the role of NMR in drug design and illustrates this role with examples studied in our laboratory in recent years on disulfide-rich peptides, including cyclotides and conotoxins. Cyclotides are head-to-tail cyclized proteins from plants that are exceptionally stable and hence make useful templates for the stabilization of bioactive peptide epitopes as well as potential leads for anti-HIV drugs. Natural cyclotides target cell membranes, so understanding cyclotide-membrane interactions is useful in applying cyclotides in drug design applications. NMR studies of these interactions are described in this article. Conotoxins are disulfide-rich peptides, from the venoms of marine cone snails, which are of pharmaceutical interest because they potently interact with a range of ion channels, transporters and other receptor sites implicated in disease states. Chemically re-engineering conotoxins to give them a cyclic backbone has been used to engender them with improved biopharmaceutical properties, such as are observed in cyclotides.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Eur Biophys J. 2009 Feb;38(2):129-43 - PubMed
    1. J Biol Chem. 2003 Nov 28;278(48):48188-96 - PubMed
    1. Eur J Pharmacol. 2000 Mar 30;393(1-3):205-8 - PubMed
    1. J Agric Food Chem. 2008 Jul 9;56(13):5237-41 - PubMed
    1. Anal Biochem. 2005 Feb 1;337(1):149-53 - PubMed

Publication types

LinkOut - more resources